120 related articles for article (PubMed ID: 34242883)
1. Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavity.
Huang WY; Ho CL; Chao TY; Lee JC; Chen JH
Am J Otolaryngol; 2021; 42(6):103156. PubMed ID: 34242883
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
Chen JH; Huang WY; Ho CL; Chao TY; Lee JC
Head Neck; 2019 Nov; 41(11):3775-3782. PubMed ID: 31435974
[TBL] [Abstract][Full Text] [Related]
3. Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
Huang WY; Ho CL; Lee CC; Hsiao CW; Wu CC; Jao SW; Yang JF; Lo CH; Chen JH
PLoS One; 2017; 12(3):e0174280. PubMed ID: 28328969
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
Hsieh MY; Chen G; Chang DC; Chien SY; Chen MK
Ann Surg Oncol; 2018 Jul; 25(7):2091-2097. PubMed ID: 29721725
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
7. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
Wang LW; Yang SH; Lin JK; Lin TC; Chan WK; Chen WS; Wang HS; Jiang JK; Lee RC; Li AF; Chao Y; Chi KH; Yen SH
J Surg Oncol; 2005 Mar; 89(4):256-63; discussion 263-4. PubMed ID: 15726610
[TBL] [Abstract][Full Text] [Related]
9. The effect of Mitomycin-C in neoadjuvant concurrent chemoradiotherapy for rectal cancer.
Wang LW; Liu YS; Jiang JK
J Chin Med Assoc; 2022 Dec; 85(12):1120-1125. PubMed ID: 36194168
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
[TBL] [Abstract][Full Text] [Related]
11. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA; Hsieh MC
Am J Cancer Res; 2023; 13(11):5504-5512. PubMed ID: 38058839
[TBL] [Abstract][Full Text] [Related]
15. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
16. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
[TBL] [Abstract][Full Text] [Related]
17. Targeted intra-arterial carboplatin chemoradiotherapy and tegafur/uracil for oral and oropharyngeal cancer.
Oya R; Takagi S; Inenaga R; Nakamura S; Ikemura K; Onari N; Imada H; Korogi Y
J UOEH; 2006 Dec; 28(4):381-94. PubMed ID: 17209514
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
19. The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience.
Yeh TJ; Chan LP; Tsai HT; Hsu CM; Cho SF; Pan MR; Liu YC; Huang CJ; Wu CW; Du JS; Wang HC
Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33672266
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
